SolasCure demonstrates proof-of-concept in Phase lla safety trial of Aurase Wound Gel

Post author:
Post published:December 12, 2023
Post category:uncategorized

SolasCure today announced the results of its proof-of-concept, first-in-human, Phase IIa safety study.

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

UPCOMING EVENTS

You Might Also Like

Do e-health interventions for smoking cessation management work?

A step forward in vaccine technology: Exploring the effects of N1-methylpseudouridine in mRNA translation

PSU receives $1.9 million grant to redesign training for educators of students with disabilities

Helpful Links

Subscribe To Us